InvestSMART

BetaShares NASDAQ 100 ETF (ASX: NDQ) - Related Research

- Current share price for NDQ : $43.550

BetaShares NASDAQ 100 ETF (NDQ) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. BetaShares NASDAQ 100 ETF (NDQ) track the performance of the NASDAQ-100 Index, before fees and expenses. The Index provides investors with exposure to the performance of the 100 largest non-financial securities listed on the NASDAQ stock market, by market capitalisation. The Index contains category-defining companies across major industry groups such as technology, telecommunications, and retail.

No research was found for NDQ but you can find our latest research below...

Health care stocks - Budget 2009

Health care was a high-risk area for a budget clampdown. In the end, the government chose to tinker around the edges, though, which is positive news for Sonic and Primary. Sigma came off worst, with funding cut for a major group of medicines.


13 May 2009
·
Article comments

Ben Graham around the Globe

We've applied some old-fashioned value investing techniques to this speculative stock. The process highlights the risky 'cigar butt' nature of this situation.


13 May 2009
·
Article comments

The search for cash-backed bargains

In our namesake book, The Intelligent Investor, Ben Graham advocated the purchase of stocks trading below ‘net cash backing’. After looking at more than 100 possibilities in a broad sweep, we have identified a small number of potential opportunities for your consideration.


07 May 2009
·
Article comments

RHG rockets

The market seems to have cottoned on to the value on offer at RHG. But we’re not selling yet.


06 May 2009
·
Article comments

Primary Health Care's big bite

From a single medical centre to one of Australia’s largest health companies, Primary Health Care is undoubtedly successful. But, following the takeover of Symbion, is it built on firm foundations or shaky ground?

06 May 2009
·
Article comments

REA Group onto the watchlist

REA Group’s Australian business is producing bucketloads of cash. In stark contrast, its foreign acquisitions are bleeding and forcing management to find a way out.


05 May 2009
·
Article comments

Great Southern TREES get the chop

It’s looking increasingly likely that Great Southern will go the way of Timbercorp. Having dusted more than 90% of our initial $100 investment in both TREES2 and TREES3, the question is what to do with the remaining 10%?

28 Apr 2009
·
Article comments

Four more capital raisings

The investment binge of recent years has given way to an almighty hangover. As companies seek to repair the damage, capital raisings are providing interesting opportunities for nimble investors.


28 Apr 2009
·
Article comments

Omens are bad for Goodman PLUS

The probability of a real estate crash is increasing. Some property groups are fortifying their balance sheets, unfortunately Goodman Group isn’t one of them.


27 Apr 2009
·
Article comments

SEEKing cash

Following a debt-fuelled foreign expansion, Seek is asking shareholders to chip in more cash. But with management treating shareholders as customers, rather than fellow business owners, is it worth risking your money?


27 Apr 2009
·
Article comments

6351 - 6375 of 14800 results

Page 255 of 592

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.